Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III RCT of two vaginal micronized progesterone formulations in AC-FET
2024-513102-57-00Phase 3Authorised
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of JL-Pro SR and progesterone in infertility (2 arms), sponsored by Fundació Santiago Dexeus Font. Primary endpoint: Ongoing pregnancy rate. Planned start Apr 2024; status: authorised.
02
Drugs
JL-Pro SRprogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on 2024-513102-57-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513102-57-00.